Page 88 - Comprehensive treatment of patients with glucocorticoid-dependent severe asthma

Chapter 4
References
1 Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218-24.
2 Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315-23.
3 Lefaudeux D, De Meulder B, Loza MJ, et al. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. J Allergy Clin Immunol. 2017;139:1797-807
4 Amelink M, de Nijs SB, de Groot JC, et al. Three phenotypes of adult-onset asthma. Allergy. 2013;68(5):674-80.
5 Gibson PG. Obesity and asthma. Ann Am Thorac Soc. 2013;10 Suppl:S138-S142.
6 Dixon AE, Pratley RE, Forgione PM, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol. 2011;128(3):508- 15.
7 Freitas PD, Ferreira PG, Silva AG et al. The Role of Exercise in a Weight-Loss Program on Clinical Control in Obese Adults with Asthma. A Randomized Controlled Trial. Am J Respir Crit Care Med.2017;195(1):32–42.
8 National Institutes of Health. NationalHeart. Report: Lung and Blood Institute. Global initiative for asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop, 2006.
9 Bousquet J, Brusselle G, Buhl R, et al. Care pathways for the selection of a biologic in severe asthma. Eur Respir J. 2017;50:1701782.
10 Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med. 2010;181(2):116-24.
11 Hashimoto S, ten Brinke A, Roldaan AC, et al. Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial. Thorax. 2011;66(6):514-20.
12 Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Hashimoto S, Bel EH, Weersink EJ. High-altitude treatment in atopic and nonatopic patients with severe asthma. Eur Respir J. 2012;40(6):1374-80.
13 Vinnikov D, Khafagy A, Blanc PD, et al. High-altitude alpine therapy and lung function in asthma: systematic review and meta-analysis. ERJ Open Res. 2016; 2:00097-2015.
14 Spieksma FT, Zuidema P, Leupen MJ. High altitude and housedust mites. Br Med J 1971;1:82–84
15 Grootendorst DC, Dahlen SE, van Den Bos JW, et al. Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy. 2001;31(3):400-8.
16 Huss-Marp J, Kramer U, Eberlein B, et al. Reduced exhaled nitric oxide values in children with asthma after inpatient rehabilitation at high altitude. J Allergy Clin Immunol. 2007;120(2):471-2.
17 Verkleij M, Beelen A, van Ewijk BE, Geenen R. Multidisciplinary treatment in children with problematic severe asthma: A prospective evaluation. Pediatr Pulmonol. 2017;52:588-597.
18 Karagiannidis C, Hense G, Rueckert B, et al. High-altitude climate therapy reduces local airway inflammation and modulates lymphocyte activation. Scand J Immunol. 2006;63(4):304-10.
19 Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99(5):553-8.
20 Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease- specific Quality of Life Questionnaire. J Clin Epidemiol. 1994;47(1):81-7.
21 Piccirillo JF, Merritt MG, Jr., Richards ML. Psychometric and clinimetric validity of the 20-Item Sino- Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg. 2002;126(1):41-7.
22 Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383-92.
23 Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319- 38.
86